News | November 01, 2011

Cardiovascular Research Foundation, Harvard Angiographic Core Lab Collaborate for Research

November 1, 2011 – The Angiographic and Imaging Core Laboratories of the Clinical Trials Center (CTC) at the Cardiovascular Research Foundation (CRF) in New York have formed a collaborative alliance with the Angiographic Core Laboratory of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HFMP). Led by distinguished physicians Gregg W. Stone, Jeffrey J. Popma and Gary S. Mintz, the collaborative research alliance will be known as CRFiCOR.

CRFiCOR is now united in contracting and performing research projects at its New York City and Boston campuses to provide expert clinical research support and comprehensive imaging Core Lab services for trial sponsors, investigators and hospitals. The new CRFiCOR alliance, as part of the CRF Clinical Trials Center, will specialize in all aspects of core laboratory analysis, including coronary angiography, carotid and peripheral angiography, intravascular imaging and structural heart disease assessment (including valve interventions), as well as electrocardiography, computed tomography (CT) and magnetic resonance (MR) imaging.

CRF’s Angiographic and Imaging Core Laboratories are one of the world’s leading centers for independent investigation, having performed highly complex analyses for hundreds of trials over the last two decades. HMFP’s Angiographic Core Laboratory has performed independent angiographic analyses and interpretations for 14 years in Boston. Collectively, CRFiCOR has performed imaging studies in more than 100,000 patients.

For more information: www.crf.org

 


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now